PLK4, a potential target against AML
- PMID: 38060272
- DOI: 10.1182/blood.2023021950
PLK4, a potential target against AML
Comment on
-
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AML.Blood. 2023 Dec 7;142(23):2002-2015. doi: 10.1182/blood.2023019782. Blood. 2023. PMID: 37738460
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous